Geode Capital Management
VOR icon

Geode Capital Management’s Vor Biopharma VOR Stock Holding History

Geode Capital Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6M Buy
1,062,469
+719,896
+210% +$10.9M ﹤0.01% 2170
2026
Q1 		$6.11M Buy
342,573
+156,765
+84% +$2.21M ﹤0.01% 2641
2025
Q4 		$2.43M Buy
185,808
+158,416
+578% +$2.95M ﹤0.01% 3094
2025
Q3 		$1.33M Buy
27,392
+5,614
+26% +$226K ﹤0.01% 3301
2025
Q2 		$706K Sell
21,778
-123
-0.6% -$1.09K ﹤0.01% 3444
2025
Q1 		$314K Buy
21,901
+794
+4% +$19.1K ﹤0.01% 3705
2024
Q4 		$469K Hold
21,107
– – ﹤0.01% 3618
2024
Q3 		$296K Sell
21,107
-135
-0.6% -$2.46K ﹤0.01% 3772
2024
Q2 		$425K Sell
21,242
-20,818
-49% -$673K ﹤0.01% 3627
2024
Q1 		$1.99M Buy
42,060
+2,357
+6% +$103K ﹤0.01% 3110
2023
Q4 		$1.79M Buy
39,703
+1,885
+5% +$77.8K ﹤0.01% 3146
2023
Q3 		$1.6M Buy
37,818
+1,698
+5% +$92.1K ﹤0.01% 3151
2023
Q2 		$2.23M Buy
36,120
+20,323
+129% +$1.86M ﹤0.01% 3076
2023
Q1 		$1.7M Buy
15,797
+7,459
+89% +$827K ﹤0.01% 3103
2022
Q4 		$1.11M Buy
8,338
+1,558
+23% +$154K ﹤0.01% 3297
2022
Q3 		$539K Buy
6,780
+1,411
+26% +$139K ﹤0.01% 3684
2022
Q2 		$533K Sell
5,369
-7,481
-58% -$766K ﹤0.01% 3727
2022
Q1 		$1.55M Buy
12,850
+311
+2% +$52.9K ﹤0.01% 3383
2021
Q4 		$2.91M Sell
12,539
-1,058
-8% -$305K ﹤0.01% 3182
2021
Q3 		$4.26M Buy
13,597
+3,861
+40% +$1.15M ﹤0.01% 3003
2021
Q2 		$3.63M Buy
9,736
+325
+3% +$160K ﹤0.01% 3081
2021
Q1 		$8.11M Buy
+9,411
New +$7.96M ﹤0.01% 2505

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $11.6B AUM 69.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Geode Capital Management's VOR Position: Q2 2026 in Review

Geode Capital Management increased its Vor Biopharma (VOR) stake by 210% in Q2 2026, buying an estimated $10.9M and bringing the position to 1,062,469 shares worth $19.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Geode Capital Management first reported a position in VOR in Q1 2021 and has held it in 22 quarters since. 39 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Geode Capital Management held 1,062,469 shares of Vor Biopharma worth $19.6M as of Q2 2026.
  • Geode Capital Management bought 719,896 Vor Biopharma shares in Q2 2026, an estimated $10.9M.
  • Vor Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2170 holding.
  • Geode Capital Management first reported a position in Vor Biopharma in Q1 2021 and has held it in 22 quarters since.
  • 39 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.